Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 2

Elektrokardiyografi k P Dalga Dispersiyonu Santral Seröz Koryoretinopatili Hastalarda Atriyal Aritmi için Bir Risk Faktörü Olabilir

Electrocardiographic P Wave Dispersion May Be a Risk Factor for Atrial Arrhythmia in The Patients With Central Serous Chorioretinopathy

Pages
122–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No signifi cant correlation was found between duration of the disorder and PWD values (r= 0.13, P > 0.05).Conclusions: Our study suggests that CSC may be associated with an increased PWD and high risk for atrial arrhythmia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to evaluate electrocardiographic P-wave dispersion (PWD) in patients with central serous chorioretinopathy (CSC).
📊
Key Findings & Data:Materials and Methods: This comparative, case-control study included 40 patients with CSC at acute phase and 40 age- and sexmatched healthy subjects.
💡
Conclusion & Impact:No signifi cant correlation was found between duration of the disorder and PWD values (r= 0.13, P > 0.05).Conclusions: Our study suggests that CSC may be associated with an increased PWD and high risk for atrial arrhythmia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study was to evaluate electrocardiographic P-wave dispersion (PWD) in patients with central serous chorioretinopathy (CSC). Materials and Methods: This comparative, case-control study included 40 patients with CSC at acute phase and 40 age- and sexmatched healthy subjects. The heart rate (HR), P maximum (Pmax), P minimum (Pmin) and PWD were manually measured and analyzed on a 12-lead surface electrocardiograms. Results: There were no signifi cant differences with regard to age, smoking status (rate and duration) and gender among the groups (P>0.05). The participants included 22 men (55%) and 18 women (45%) in the patient group, 20 men (50%) and 20 women (50%) in the control group. The mean Pmax, Pmin, and PWD in the patient group were signifi cantly higher than those of the control group (p=0. 001, p=0. 01 and p=0. 04, respectively). HR did not differ signifi cantly between the study groups (P>0.05). No signifi cant correlation was found between duration of the disorder and PWD values (r= 0.13, P > 0.05).Conclusions: Our study suggests that CSC may be associated with an increased PWD and high risk for atrial arrhythmia.

Özet

Amaç: Bu çalışmanın amacı santral seröz koryoretinopati (SSKR)li hastalarda elektrokardiyografi k p dalga dispersiyonu(PDD)nu değerlendirmek amaçlandı. Gereç ve Yöntem: Bu kıyaslamalı, vaka kontrol çalışması akut evredeki 40 SSKR hastasını ve yaş ve cins olarak benzer 40 sağlıklı kişiyi içerdi. Kalp hızı, P maksimum (Pmaks), P minimum (Pmin) and PDD 12-derivasyonlu elektrokardiyogramda manuel olarak ölçüldü ve analiz edildi. Bulgular: Gruplar arasında yaş, sigara içim (miktar ve süre) ve cins açısından anlamlı fark yoktu (p>0.05). Hasta grubundaki katılımcıların 22'si erkek (%55) ve 18'i kadındı (%45); kontrol grubundakilerin 20'si erkek (%50), yirmisi kadındı (%50). Ortalama Pmaks, Pmin, ve PDD hasta grubunda control grubundakilerden anlamlı derecede daha yüksekti (sırasıyla, p=0.001, p=0.01 ve p=0.04). Kalp hızı çalışma grupları arasında anlamlı farklılık göstermedi (p>0.05). Hastalık süresi ve PDD değerleri arasında anlamlı korelasyon bulunmadı (r= 0.13, P > 0.05).Sonuç: Çalışmamız SSKR'nin artmış PDD ve yüksek atriyal aritmi riski ile ilişkili olabileceğini ileri sürmektedir.

🔖

Cite This Article

TURGUT, B., DAĞLI, N., KOBAT, S. G., TANYILDIZI, R., DOĞDU, O., KOBAT, M. A. (2017). Elektrokardiyografi k P Dalga Dispersiyonu Santral Seröz Koryoretinopatili Hastalarda Atriyal Aritmi için Bir Risk Faktörü Olabilir. Retina-Vitreus, Cilt: 26 - Sayı: 2, 122–126. https://ajindex.com/articles/304946

References (15)

  1. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina. 2012; 32: 709
  2. Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol. 2011; 22: 166-73
  3. Quin G, Liew G, Ho IV, Gillies M, Fraser-Bell S. Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Experiment Ophthalmol. 2013: 41: 187-200
  4. Li L, Li DH, Yang ZK, Bian AL, Chen YX, Dong FT. [Analysis of fundus fl uorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy]. Zhonghua Yan Ke Za Zhi. 2012; 48: 878-82
  5. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003; 110: 698-703
  6. Eckstein MB, Spalton DJ, Holder G. Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol. 1993; 77: 607-9
  7. Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2013; 33: 2096-102
  8. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome: prospective longitudinal study on 382 families. Circulation. 1991; 84: 1136-44
  9. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. Circulation. 1991; 84: 503-11
  10. Tatham A, Macfarlane A. The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT. J Ocul Pharmacol Ther. 2006; 22: 145-9
  11. Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013; 58: 103-26
  12. Davies LG, Ross IP. Abnormal P waves and paroxysmal tachycardia. Br Heart J. 1963; 25; 570-4
  13. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fi brillation. Am Heart J. 1998; 135: 733-8
  14. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, et al. Clinical and electrocardiographic predictors of recurrent atrial fi brillation. Pacing Clin Electrophysiol. 2000; 23: 352-8
  15. Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, et al. P wave dispersion on 12-lead electrocardiography in pa